Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by Baxter Healthcare Corporation.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Baxter Healthcare Corporation
ClinicalTrials.gov Identifier:
NCT01234883
First received: November 3, 2010
Last updated: April 20, 2011
Last verified: April 2011

November 3, 2010
April 20, 2011
December 2010
April 2012   (final data collection date for primary outcome measure)
venous serum bicarbonate [ Time Frame: 4 hour ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01234883 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis
A Double-Blind, Randomized, Comparative Efficacy and Safety Trial of Intravenous Solutions for the Treatment of Moderate to Severe Dehydration in Children With Acute Gastroenteritis

The primary objective of this study is to compare the efficacy and safety of the use of a multiple electrolyte solution to the use of saline for the treatment of moderate to severe dehydration due to acute gastroenteritis (AGE) in children.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
  • Dehydration
  • Gastroenteritis
  • Drug: multiple electrolyte solution
    IV multiple electrolyte solution clinically dosed for rehydration
  • Drug: saline
    IV saline solution dosed for clinical rehydration
  • Experimental: multiple electrolyte solution
    Intervention: Drug: multiple electrolyte solution
  • Active Comparator: saline
    Intervention: Drug: saline
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
112
April 2012
April 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. AGE (etiology: viral or other) resulting in the presentation to the ED deemed in need of IV rehydration. In the 24 hours prior to presentation, the patient must have experienced at least 3 episodes of diarrhea (loose and/or watery stools) and/or nonbilious vomiting.
  2. Moderate to severe dehydration (i.e., Gorelick score ≥ 4;)
  3. ≥ 6 months to < 11 years of age
  4. Healthy except for the underlying etiology of AGE

Exclusion Criteria:

  1. AGE that does not require IV rehydration per the ED clinician
  2. Gorelick score ≤ 3
  3. Bilious vomiting
  4. Received > 20 mL/kg IV fluid bolus within 4 hours prior to Study Enrollment
  5. Diarrhea lasting > 5 days prior to admission to the ED
  6. Chronic vomiting disorder
  7. Grossly bloody diarrhea
  8. Chronic diarrheal disorder
  9. Known hyponatremia within 72 hours prior to enrollment
  10. Known hypernatremia within 72 hours prior to enrollment
  11. Known hypokalemia within 72 hours of prior to enrollment
  12. Known hyperkalemia within 72 hours prior to enrollment
  13. The use of any prohibited medications

    • Antacids within 24 hours prior to presentation to the ED and during the study
    • Anti-diarrhea medication within 24 hours prior to presentation to the ED and during the study
    • The systemic use of corticosteroids/corticotropins is prohibited within 72 hours of enrollment
  14. Chronic health condition affecting the ability to tolerate fluids or those that result in electrolyte abnormalities or abnormalities of sodium or potassium handling
Both
6 Months to 10 Years
No
Contact: Katherine Weber, BS 847-948-3037 katherine_weber@baxter.com
Contact: Carol Schermer, MD 847-948-4124 carol_schermer@baxter.com
United States,   Canada
 
NCT01234883
CSPIVTUSA001
No
Katherine Weber, Baxter Healthcare
Baxter Healthcare Corporation
Not Provided
Not Provided
Baxter Healthcare Corporation
April 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP